EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Rhabdomyolysis in the Era of Next-Generation Sequencing: Selecting Patients with a High Likelihood of a Genetic Susceptibility Using ‘RHABDO’ Features

Nick Kruijt iD, Sanne A J H van de Camp iD, Jasper J Kramer iD, Luuk R van den Bersselaar iD, Meyke Schouten, Thatjana Gardeitchik, Heinz Jungbluth iD, Salman Bhai iD, Anneke J van der Kooi, Erik-Jan Kamsteeg, Nicol C Voermans

Genes · 25.08.2025 · 16 (9) · 995

DOI: 10.3390/genes16090995 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Genes, online erschienen am 25.08.2025. Verfasst von Nick Kruijt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Radboudumc Research Institute for Medical Innovation, Donders Institute for Brain, Cognition and Behaviour, Radboud Universi…. Hauptthemen laut MEDLINE: Rhabdomyolysis, High-Throughput Nucleotide Sequencing, Genetic Predisposition to Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Rhabdomyolysis is a potentially life-threatening condition characterized by acute skeletal muscle breakdown. In addition to well-described external triggers, a genetic contribution is increasingly recognized. We aimed to (I) review the genetic diagnostic approach of rhabdomyolysis, (II) evaluate the clinical characteristics indicative of a genetic susceptibility with the ‘RHABDO’ acronym, and (III) assess the predictive value of the presence RHABDO features for identifying genetic variants.

Methods

In this retrospective two-center study, 122 patients underwent genetic testing for rhabdomyolysis since the introduction of whole exome sequencing (WES) in 2013. The presence of RHABDO features was compared between those with (likely) pathogenic variants and those with benign or no identified variants or variants of uncertain significance.

Results

The testing methods included panel-based WES (82%), Sanger sequencing (49%), and full WES (24%), of which 52 patients (43%) underwent multiple methods. A (likely) pathogenic variant was identified in 13 patients (11%), in all of whom ≥2 RHABDO features were present. The positive predictive value for ≥2 features was 14%, while the negative predictive value was 100%.

Conclusions

These results highlight the relevance of WES in further elucidating the genetic basis of rhabdomyolysis and demonstrated that RHABDO is a valuable tool for selecting patients who should undergo genetic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyolysisHigh-Throughput Nucleotide SequencingGenetic Predisposition to DiseaseHumansMaleFemaleGenetic TestingRetrospective StudiesChild, PreschoolInfantExome SequencingChildAdult

Stichwörter der Autor:innen

genetic predisposition to diseasegeneticsneuromuscular disordersnext-generation sequencingrhabdomyolysis

Autor:innen und Institutionen

  • Department of Neurology, Radboudumc Research Institute for Medical Innovation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 XZ Nijmegen, The Netherlands.
  • Malignant Hyperthermia Investigation Unit, Department of Anesthesiology, Canisius Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands.
  • Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Muscle Signalling Section, Randall Centre for Cell and Molecular Biophysics, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London SE1 1UL, UK.
  • Department of Paediatric Neurology, Neuromuscular Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital NHS Foundation Trust, London SE1 7EH, UK.

ORCID-Profile: Nick Kruijt, Sanne A J H van de Camp, Jasper J Kramer, Luuk R van den Bersselaar, Heinz Jungbluth, Salman Bhai

Zitieren

APA

Kruijt, N., van de Camp, S. A. J. H., Kramer, J. J., van den Bersselaar, L. R., Schouten, M., Gardeitchik, T., Jungbluth, H., Bhai, S., van der Kooi, A. J., Kamsteeg, E. J., & Voermans, N. C. (2025). Rhabdomyolysis in the Era of Next-Generation Sequencing: Selecting Patients with a High Likelihood of a Genetic Susceptibility Using ‘RHABDO’ Features. Genes, 16(9), 995. https://doi.org/10.3390/genes16090995

Vancouver

Kruijt N, van de Camp SAJH, Kramer JJ, van den Bersselaar LR, Schouten M, Gardeitchik T, et al. Rhabdomyolysis in the Era of Next-Generation Sequencing: Selecting Patients with a High Likelihood of a Genetic Susceptibility Using ‘RHABDO’ Features. Genes. 2025;16(9):995. doi:10.3390/genes16090995

BibTeX
@article{Kruijt2025,
  author = {Kruijt, Nick and van de Camp, Sanne A J H and Kramer, Jasper J and van den Bersselaar, Luuk R and Schouten, Meyke and Gardeitchik, Thatjana and Jungbluth, Heinz and Bhai, Salman and van der Kooi, Anneke J and Kamsteeg, Erik-Jan and Voermans, Nicol C},
  title = {Rhabdomyolysis in the Era of Next-Generation Sequencing: Selecting Patients with a High Likelihood of a Genetic Susceptibility Using ‘RHABDO’ Features},
  journal = {Genes},
  year = {2025},
  volume = {16},
  number = {9},
  pages = {995},
  doi = {10.3390/genes16090995}
}
Kostenlos starten →